These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33501588)

  • 1. The soluble glutathione transferase superfamily: role of Mu class in triclabendazole sulphoxide challenge in Fasciola hepatica.
    Stuart RB; Zwaanswijk S; MacKintosh ND; Witikornkul B; Brophy PM; Morphew RM
    Parasitol Res; 2021 Mar; 120(3):979-991. PubMed ID: 33501588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single amino acid substitution in isozyme GST mu in Triclabendazole resistant Fasciola hepatica (Sligo strain) can substantially influence the manifestation of anthelmintic resistance.
    Fernández V; Estein S; Ortiz P; Luchessi P; Solana V; Solana H
    Exp Parasitol; 2015 Dec; 159():274-9. PubMed ID: 26542261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative proteomic analysis of triclabendazole response in the liver fluke Fasciola hepatica.
    Chemale G; Perally S; LaCourse EJ; Prescott MC; Jones LM; Ward D; Meaney M; Hoey E; Brennan GP; Fairweather I; Trudgett A; Brophy PM
    J Proteome Res; 2010 Oct; 9(10):4940-51. PubMed ID: 20726552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro effects of triclabendazole (TCBZ) on the excretory-secretory products (ESP) of Fasciola spp parasites.
    Farahnak A; Golmohamdi T; Eshraghian M
    Acta Med Iran; 2012; 50(3):164-8. PubMed ID: 22418984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
    Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
    Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot Evaluation of Two
    Collett CF; Morphew RM; Timson D; Phillips HC; Brophy PM
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751696
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
    Mottier L; Alvarez L; Fairweather I; Lanusse C
    J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of triclabendazole sulphoxide-induced tegumental disruption by methimazole in a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2010 May; 106(6):1351-63. PubMed ID: 20336319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica.
    Davis CN; Winters A; Milic I; Devitt A; Cookson A; Brophy PM; Morphew RM
    Sci Rep; 2020 Aug; 10(1):13445. PubMed ID: 32778698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica.
    Robinson MW; Lawson J; Trudgett A; Hoey EM; Fairweather I
    Parasitol Res; 2004 Feb; 92(3):205-10. PubMed ID: 14652740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of triclabendazole metabolism in vitro by ketoconazole increases disruption to the tegument of a triclabendazole-resistant isolate of Fasciola hepatica.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Parasitol Res; 2011 Oct; 109(4):981-95. PubMed ID: 21442257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica.
    Solana H; Scarcella S; Virkel G; Ceriani C; Rodríguez J; Lanusse C
    Vet Res Commun; 2009 Feb; 33(2):163-73. PubMed ID: 18726703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of gluthatione S-transferase, carboxyl esterase and carbonyl reductase in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Solana MV; Fernandez V; Lamenza P; Ceballos L; Solana H
    Mol Biochem Parasitol; 2013 Oct; 191(2):63-5. PubMed ID: 24041589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.
    Meaney M; Savage J; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2013 Sep; 140(10):1287-303. PubMed ID: 23756576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasciola hepatica: histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA strand breaks.
    Hanna RE; Forster FI; Brennan GP; Fairweather I
    Vet Parasitol; 2013 Jan; 191(3-4):240-51. PubMed ID: 23062689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia.
    Elliott T; Muller A; Brockwell Y; Murphy N; Grillo V; Toet HM; Anderson G; Sangster N; Spithill TW
    Vet Parasitol; 2014 Feb; 200(1-2):90-6. PubMed ID: 24360656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Threat of Triclabendazole Resistance in Fasciola hepatica.
    Kelley JM; Elliott TP; Beddoe T; Anderson G; Skuce P; Spithill TW
    Trends Parasitol; 2016 Jun; 32(6):458-469. PubMed ID: 27049013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative assessment of albendazole and triclabendazole ovicidal activity on Fasciola hepatica eggs.
    Alvarez L; Moreno G; Moreno L; Ceballos L; Shaw L; Fairweather I; Lanusse C
    Vet Parasitol; 2009 Oct; 164(2-4):211-6. PubMed ID: 19560276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.